pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
ELREXFIO
ELREXFIO (ELRANATAMAB)
1 INDICATIONS AND USAGE ELREXFIO is indicated for the treatment of adult pati…
T cell surface glycoprotein CD3Tumor necrosis factor receptor superfamily member 17
$PFEPFIZER INC
0 catalysts
ELTROMBOPAG
ELTROMBOPAG (ELTROMBOPAG)
ZYDUS PHARMS
0 catalysts
Phase 2
ELU-42
Diabetic Foot Ulcers
Eluciderm Inc
0 catalysts
← prev
page 90 of 271
next →
131
Pain89
Neurology1
ELURYNG
ELURYNG (ETONOGESTREL AND ETHINYL ESTRADIOL)
AMNEAL
0 catalysts
Phase 1
ELVN-001
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$ELVNEnliven Therapeutics, Inc.
0 catalysts
Phase 2
ELVN-002
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
$ELVNEnliven Therapeutics, Inc.
0 catalysts
Preclinical
EMD-101
Neutropenia
EmendoBio Inc
0 catalysts
Preclinical
EMD-202
Retinitis Pigmentosa (Retinitis)
EmendoBio Inc
0 catalysts
Preclinical
EMDRX-9
cannabidiol
Pain
Emyria Ltd
0 catalysts
EMROSI
EMROSI (MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE)
JOURNEY
0 catalysts
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (EMTRICITABINE)
Macleods Pharmaceuticals Ltd
0 catalysts
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
CHARTWELL RX
0 catalysts
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE (EMTRICITABINE)
Apotex Corp
0 catalysts
Phase 2
EN-374
Chronic Granulomatous Disease
Ensoma Inc
0 catalysts
ENALAPRIL MALEATE ORAL SOLUTION
ENALAPRIL MALEATE ORAL SOLUTION (ENALAPRIL MALEATE ORAL SOLUTION)
ALKEM LABS LTD
0 catalysts
Phase 2
ENB-003
Pancreatic Cancer
ENB Therapeutics LLC
0 catalysts
Phase 3
ENB-106
Diabetic Retinopathy
Ennovabio
0 catalysts
Phase 3
ENERGIF-703
Diabetic Foot Ulcers
Energenesis Biomedical Co Ltd
0 catalysts
ENHERTU
ENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI)
Daiichi Sankyo Co Ltd
0 catalysts
ENOXAPARIN SODIUM (PRESERVATIVE FREE)
ENOXAPARIN SODIUM (PRESERVATIVE FREE) (ENOXAPARIN SODIUM)
Shenzhen Techdow Pharmaceutical Co Ltd
0 catalysts
Phase 1
ENS-002
Atopic Dermatitis (Atopic Eczema)
Concerto Biosciences Inc
0 catalysts
ENSACOVE
ENSACOVE (ENSARTINIB HYDROCHLORIDE)
Xcovery Holdings Inc
0 catalysts
Phase 1
ENV-308
Obesity
Enveda Biosciences Inc
0 catalysts
Phase 1
ENV-6946
Inflammatory Bowel Disease
Enveda Biosciences Inc
0 catalysts
ENZEEVU
ENZEEVU (AFLIBERCEPT-ABZV)
Sandoz Inc
0 catalysts
Phase 1
EO-2002
Corneal Edema
Emmecell LLC
0 catalysts
Phase 2
EO-2463
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
Enterome Bioscience SA
0 catalysts
EOVIST
EOVIST (GADOXETATE DISODIUM)
BAYER HLTHCARE
0 catalysts
Preclinical
EP-055
Male Contraception
Eppin Pharma Inc
0 catalysts
Phase 2
EPI-321
Facioscapulohumeral Muscular Dystrophy (FSHD)
Epicrispr Biotechnologies Inc
0 catalysts